|
| Status |
Public on Sep 15, 2015 |
| Title |
MM_qeNxi |
| Sample type |
genomic |
| |
|
| Source name |
Bone marrow
|
| Organism |
Homo sapiens |
| Characteristics |
tumor: multiple myeloma
tissue: bone marrow
cell type: purified CD138+ plasma cells
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
DNA was extracted using the DNA AllPrep DNA/RNA MiniKit (Qiagen, Valencia, CA). DNA quality and quantity were assessed using the Nanodrop Spectrophotometer (NanoDrop Technologies, Inc. Wilmington, DE).
|
| Label |
Biotin
|
| Label protocol |
According to manufacturer protocol
|
| |
|
| Hybridization protocol |
DNA was restriction digested, PCR amplified, fragmented, labeled and hybridized to each array according to the manufacturer's instructions.
|
| Scan protocol |
Arrays were scanned using the GeneChip Scanner 3000 7G.
|
| Description |
SUBMITTER_COMMENT: Relevant clinical data are included in the original paper, please read the article.
|
| Data processing |
Affymetrix Genotyping Console 4.0 for processing SNPs, detecting copy number abnormalities with default parameters.
|
| |
|
| Submission date |
Oct 25, 2011 |
| Last update date |
Sep 15, 2015 |
| Contact name |
Wilfried Gouraud |
| Organization name |
ICO - UMGC
|
| Department |
Integrated Center of Oncology René Gauducheau
|
| Lab |
Omics Data Science Unit
|
| Street address |
bd Jacques Monod
|
| City |
Saint Herblain |
| ZIP/Postal code |
44805 |
| Country |
France |
| |
|
| Platform ID |
GPL6801 |
| Series (1) |
| GSE31272 |
NF-kB activation confers a prolonged event-free-survival in newly diagnosed myeloma patients harboring t(4;14) treated with bortezomib. |
|
